Jean-Pierre Raynaud
12Patents
7h-index
5Co-inventors
59Inventor score
Filing activity: Jun 15, 1978 → Sep 28, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4472382A | Treatment method | Emerging Cross-Sectional Technologies | 95 | Expired |
| US6599540B1 | Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer | Human Necessities | 15 | Expired |
| US4728640A | Treatment of dysmenorrhea | Emerging Cross-Sectional Technologies | 14 | Expired |
| US4743589A | Treatment of endometriosis | Emerging Cross-Sectional Technologies | 13 | Expired |
| US4745102A | Novel treatment method | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5389613A | Method of treating prostate adenocarcinoma, prostate benign hypertrophia and endometriosis | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4851386A | Method of treating precocious puberty | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5189021A | Method of treating precocious puberty | Human Necessities | 6 | Expired |
| US4981842A | Method of treating hormonal dependent mammary tumors in female mammals | Emerging Cross-Sectional Technologies | 4 | Expired |
| US4191697A | Novel steroids | Chemistry; Metallurgy | 1 | Expired |
| US5688769A | Treatment method | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5712251A | Treatment method | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.